RevMAb Biosciences USA, Inc is a biotechnology company focused on the development of recombinant monoclonal antibodies

using a revolutionary technology that does not require cell fusion and hybridoma generation.

Our mission is to promote personal health by accelerating biomedical research and advancing disease diagnosis.

We seek to accomplish this by providing superior monoclonal antibodies to our customers in the research and diagnostic fields.